Black Sea Journal of Health Science
Yazarlar: Sevil ALKAN ÇEVİKER, Özgür GÜNAL
Konular:Tıp
Anahtar Kelimeler:Ankylosing Spondylitis,Cytomegalovirus,Pneumonia,Adalimumab
Özet: Nowadays, biological agents such as anti-tumor necrosis factor alpha (anti-TNFα) drugs are used in the treatment of many chronic inflammatory diseases, particularly in those cases that do not respond to conventional treatments. However, infrequently, opportunistic infections such as bacterial, viral, fungal and parasitic infections may develop in patients treated with anti-TNF therapy, and physicians should be cautious in terms of increased risk of infection when using these agents. In this case report, we present a case of bilateral Cytomegalovirus (CMV) pneumonia in an adalimumab treated patient due to ankylosing spondylitis.